Arkolith/Insider Trading/EWTX/Form 4

Edris Badreddin

DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.4M
Net Open-Market Flow
-$3.4M
Transactions
15
10 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)14K$29.44$403K122K
Jan 21, 2026Option exercise(M)8K$0.71$5K135K
Jan 21, 2026Option exercise(M)10K$1.93$20K61K
Jan 21, 2026Option exercise(M)17K$0.64$11K51K
Jan 21, 2026Option exercise(M)14K$0.39$5K34K
Jan 21, 2026Option exercise(M)66K$1.93$128K128K
Jan 21, 2026Sell(S)66K$29.44$2.0M20K
Jan 21, 2026Sell(S)10K$29.44$308K86K
Jan 21, 2026Sell(S)17K$29.44$507K104K
Jan 21, 2026Sell(S)8K$29.44$224K97K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 21, 2026Option exercise(M)66K—$00
Jan 21, 2026Option exercise(M)14K—$00
Jan 21, 2026Option exercise(M)17K—$00
Jan 21, 2026Option exercise(M)8K—$00
Jan 21, 2026Option exercise(M)10K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001786966-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML